The traditional APIs segment accounted for the largest share in 2024, whereas the HPAPI segment is expected to grow at the fastest CAGR over the forecast period. The HPAPI segment is further segmented ...

Novartis will add a new North Carolina facility for active pharmaceutical ingredient (API) manufacturing for solid dosage ...

The market offers growth opportunities driven by increased demand for personalized medicine, advancements in cell and gene ...

SAN FRANCISCO, April 29, 2025 /PRNewswire/ -- The global active pharmaceutical ingredients market size is projected to reach USD 359.45 billion by 2030, and it is expected to exhibit a CAGR of 5.85% ...

(MENAFN- EIN Presswire) EINPresswire/ -- The biologics active pharmaceutical ingredient (API) market has shown impressive growth recently, driven by several key factors in healthcare and ...

The MarketWatch News Department was not involved in the creation of this content. AUSTIN, Texas and TOKYO, Oct. 3, 2025 /PRNewswire/ -- According to DataM Intelligence, the Active Pharmaceutical ...

Dublin, Feb. 10, 2026 (GLOBE NEWSWIRE) -- The "Active Pharmaceutical Ingredients Directory" directory has been added to ResearchAndMarkets.com's offering. Published annually the Active Pharmaceutical ...

DUBLIN, May 10, 2021 /PRNewswire/ -- The "Global Active Pharmaceutical Ingredient Market (2020-2025) by Type, Molecule, Product Type, Formulation Type, Manufacturing Type, Synthesis Type, Drug Type, ...

DUBLIN--(BUSINESS WIRE)--The "United States Active Pharmaceutical Ingredients Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2024" report has been added to ...